How we do business

How we evaluate our investment options

Over our recent history, we have completed a number of corporate transactions that have redefined the shape of GSK and realised significant value for our shareholders.

How we do business

Changing the way we work with healthcare professionals

We are leading the industry in changing the way we work with doctors and other healthcare professionals. Our Chief Medical Officer, Murray Stewart, explains how these changes put patients’ interests at the heart of every decision we take.

How we do business

Disclosing information on payments to doctors has already had positive effects in Europe

From June 2016, we will publicly disclose information on payments and transfers of value that we make to doctors and other healthcare professionals (HCPs) in Europe as part of an initiative by the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Back to top